6MN-11517-04706

4 vaccinations 11 coded responses 42 check-ins 10 free-text entries 8 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 257 / WV
Registered: 2021-01-05

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2595530 (opens in a new window)	low	10 / 11	8	2 of 6 VAERS symptoms	same dose (4)	VA differs	2022-09-09 / 2022-10-01 / 2023-03-13 received the same day as the last call	case 332401

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Moderna
2021-01-06
Survey response — days 1–6 daily, dose 1
MedDRA: Condition aggravated, Hypoaesthesia, Pre-existing disease — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Slightly increased neuropathy symptoms and numbness in face

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-06
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-07
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-08
Survey response — days 1–6 daily, dose 1
MedDRA: Dehydration, Diarrhoea — Feeling: Poor · Site: Itching · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Free text: Diarrhea started shortly after yesterday's check-in and caused dehydration

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-10
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-11
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Health check-in — day 7, dose 1
Feeling: Good · Fever · Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-01-26
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-02-03
Dose 2 — Moderna
2021-02-03
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-04
Survey response — days 1–6 daily, dose 2
MedDRA: Bone pain — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Bone pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Vomiting, Abdominal pain

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-10
Health check-in — day 7, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-17
Survey response — day 14, dose 2
MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Fair

Free text: Mild sore throat and stuffy nose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-03-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-11-02
Dose 3 — Moderna
2021-11-02
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-03
Survey response — days 1–6 daily, dose 3
MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness

Free text: Sneezing, running nose

MedDRA releases: 2024-11 · check-in free text available
2021-11-04
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-11-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-11-09
Health check-in — day 7, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-11-21
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-23
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-30
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-15
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-03
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-04
Survey response — 6 months, dose 3
MedDRA: Condition aggravated, Nasopharyngitis, Pre-existing disease, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Hyperadregenic POTS flare following contraction of a cold in February. Did not test positive for Covid-19.

MedDRA releases: 2024-11 · check-in free text available
2022-05-04
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-05
Call 1 — Left Voicemail
2022-05-24
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-09-09
Dose 4 — Moderna
Co-administered: Flu
2022-09-14
Survey response — days 1–6 daily, dose 4
MedDRA: Breakthrough COVID-19, COVID-19 — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Ongoing symptoms from breakthrough Covid infection in May

MedDRA releases: 2024-11 · check-in free text available
2022-09-18
Survey response — day 7, dose 4
MedDRA: Breakthrough COVID-19, Cough, Pleuritic pain, Pneumonitis — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Ongoing lung inflammation (pleural pain and cough) since breakthrough Covid infection in May 2022

MedDRA releases: 2024-11 · check-in free text available
2022-09-24
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-09-30
Survey response — day 21, dose 4
MedDRA: Adverse drug reaction, Inflammation — Feeling: Good

Free text: Bleeding/bruising apparently associated with new NSAID prescription to reduce systemic inflammation.

MedDRA releases: 2024-11 · check-in free text available
2022-10-08
Health check-in — day 28, dose 4
Feeling: Fair

Adult check-in
2022-10-16
Health check-in — day 35, dose 4
Feeling: Fair

Adult check-in
2022-12-09
Survey response — 3 months, dose 4
MedDRA: COVID-19, Hypersensitivity, Inflammation, Lymphadenopathy, Pleuritic pain, Pulmonary pain, Skin infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Fighting allergic reaction to material in HVAC system, systemic inflammatory response; skin infection, and poss. abscessed lymph nodes and lymphatic swelling in neck since Oct; pleurtitc lung pain since covid in May (infected 6 mo after 3rd booster)

MedDRA releases: 2024-11 · check-in free text available
2022-12-09
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-12
Call 1 — Could Not Reach Participant
2023-03-12
Survey response — 6 months, dose 4
MedDRA: Abdominal pain, Gallbladder polyp, Steatorrhoea, Tinnitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-12
Report sent to call center — 6 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-13
Call successful
Completed over the phone
2023-03-13
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Moderna
2	2021-02-03	Moderna
3	2021-11-02	Moderna	No
4	2022-09-09	Moderna	Flu

Call center

8 call center cases

3 successful · 5 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-06

Systemic reaction (other): Slightly increased neuropathy symptoms and numbness in face

2021-01-08

Systemic reaction (other): Diarrhea started shortly after yesterday's check-in and caused dehydration

Release 3 — days 1–6 daily, dose 2

2021-02-04

Systemic reaction (other): Bone pain

Release 4 — day 14, dose 2

2021-02-17

Symptoms: Mild sore throat and stuffy nose

Release 10 — days 1–6 daily, dose 3

2021-11-03

Systemic reaction (other): Sneezing, running nose

Release 11 — 6 months, dose 3

2022-05-04

Symptoms: Hyperadregenic POTS flare following contraction of a cold in February. Did not test positive for Covid-19.

Release 12 — days 1–6 daily, dose 4

2022-09-14

Systemic reaction (other): Ongoing symptoms from breakthrough Covid infection in May

Release 12 — day 7, dose 4

2022-09-18

Systemic reaction (other): Ongoing lung inflammation (pleural pain and cough) since breakthrough Covid infection in May 2022

Release 12 — day 21, dose 4

2022-09-30

Symptoms: Bleeding/bruising apparently associated with new NSAID prescription to reduce systemic inflammation.

Release 12 — 3 months, dose 4

2022-12-09

Symptoms: Fighting allergic reaction to material in HVAC system, systemic inflammatory response; skin infection, and poss. abscessed lymph nodes and lymphatic swelling in neck since Oct; pleurtitc lung pain since covid in May (infected 6 mo after 3rd booster) cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	·	·	✓
SD	Adverse drug reaction	·	·	✓
SD	Condition aggravated	·	·	✓
SD	COVID-19	·	·	✓
SD	Gallbladder polyp	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Inflammation	·	·	✓
SD	Lymphadenopathy	·	·	✓
SD	Nasal congestion	✓	✓	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pleuritic pain	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Pulmonary pain	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Skin infection	·	·	✓
SD	Steatorrhoea	·	·	✓
SD	Tinnitus	·	·	✓
SRO	Bone pain	✓	✓	✓
SRO	Breakthrough COVID-19	·	·	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Cough	·	·	✓
SRO	COVID-19	·	·	✓
SRO	Dehydration	✓	✓	✓
SRO	Diarrhoea	✓	✓	✓
SRO	Hypoaesthesia	✓	✓	✓
SRO	Pleuritic pain	·	·	✓
SRO	Pneumonitis	·	·	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Rhinorrhoea	·	·	✓
SRO	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release